ctrl K

Watchlist Price Alert

Impel Pharmaceuticals Inc... (IMPL)

NASDAQ: IMPL · Real-Time Price · USD

0.04

-0.01 (-27.27%)

At close: Dec 20, 2023, 8:58 PM

Impel Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	12.65M	668K	n/a	n/a
Cost of Revenue	6.5M	691K	n/a	n/a
Gross Profit	6.16M	-23K	n/a	n/a
Operating Income	-83.18M	-71.49M	-45.33M	-41.57M
Interest Income	10.58M	2.25M	n/a	417K
Pretax Income	-106.31M	-76.53M	-45.8M	-41.83M
Net Income	-129.44M	-76.54M	-45.8M	-41.86M
Selling & General & Admin	77.89M	50.9M	18.05M	12.75M
Research & Development	11.46M	20.56M	27.29M	28.81M
Other Expenses	-9.29M	-5.05M	-408K	-680K
Operating Expenses	89.34M	71.46M	45.33M	41.57M
Interest Expense	13.84M	n/a	n/a	n/a
Selling & Marketing Expenses	7.6M	12.6M	n/a	n/a
Cost & Expenses	95.84M	72.15M	45.33M	41.57M
Income Tax Expense	23.13M	2K	1K	30K
Shares Outstanding (Basic)	23.45M	14.6M	13.14M	13.14M
Shares Outstanding (Diluted)	23.45M	14.6M	13.14M	13.14M
EPS (Basic)	-5.52	-5.24	-3.49	-3.19
EPS (Diluted)	-5.52	-5.24	-3.49	-3.19
EBITDA	-83.18M	-70.4M	-44.26M	-40.84M
EBIT	-92.48M	n/a	n/a	n/a
Depreciation & Amortization	1.2M	1.09M	1.08M	722K